MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by BIRKETT, D. J.
Right arrow Articles by SUDLOW, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by BIRKETT, D. J.
Right arrow Articles by SUDLOW, G.

Molecular Pharmacology, Vol 13, 987-992, Copyright © 1977 by the American Society for Pharmacology and Experimental Therapeutics

Effects of Fatty Acids on Two Specific Drug Binding Sites on Human Serum Albumin

DONALD J. BIRKETT 1, SHIRLEY P. MYERS 1, and GILLIAN SUDLOW 1

1 Department of Clinical Pharmacology, St. Vincent’s Hospital, Darlinghurst, New South Wales 2010 Australia

Two distinct binding sites, I and II, for anionic drugs on human serum albumin have previously been demonstrated using fluorescent probe techniques. 5-Dimethylaminonaphthalene-1-sulfonamide (DNSA) and dansylsarcosine are specific fluorescent probes for sites I and II, respectively. The addition of fatty acids results in differing effects at the two binding sites, and the specificity of site II is lost. The order of potency of various fatty acids in causing these changes is oleic > stearic > linoleic [unknown] palmitic, and this is the same as the order of association constants for these fatty acids. It is concluded that chain length and degree of unsaturation determine both binding affinity and the extent to which the fatty acids induce configurational adaptations in the albumin molecule. Furthermore, studies with varying ratios of oleic acid to albumin suggest that the conformational changes induced in the protein are different for each molecule of oleic acid added. Addition of oleic acid at a 3:1 molar ratio with albumin significantly increased the binding of warfarin and DNSA to site I.

Submitted on February 8, 1977
Accepted on May 27, 1977




This article has been cited by other articles:


Home page
 Anesth. Analg.Home page
M. Sueyasu, K. Fujito, H. Shuto, T. Mizokoshi, Y. Kataoka, and R. Oishi
Protein Binding and the Metabolism of Thiamylal Enantiomers In Vitro
Anesth. Analg., September 1, 2000; 91(3): 736 - 740.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
A. E. A. Thumser, A. G. Buckland, and D. C. Wilton
Monoacylglycerol binding to human serum albumin: Evidence that monooleoylglycerol binds at the dansylsarcosine site
J. Lipid Res., May 1, 1998; 39(5): 1033 - 1038.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
I. Petitpas, A. A. Bhattacharya, S. Twine, M. East, and S. Curry
Crystal Structure Analysis of Warfarin Binding to Human Serum Albumin. ANATOMY OF DRUG SITE I
J. Biol. Chem., June 15, 2001; 276(25): 22804 - 22809.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1977 by the American Society for Pharmacology and Experimental Therapeutics